Reunion Island Launches Monkeypox Vaccine Campaign 💉

0 comments

Mpox Outbreak: Vaccination Campaigns Expand as Cases Rise in French Territories

Health authorities are responding to a recent increase in Mpox (formerly known as monkeypox) cases, particularly in the French overseas territories of Réunion and Mayotte, as well as a confirmed case in mainland France. Vaccination campaigns are now underway in Réunion, while health responses have been strengthened in Mayotte following a cluster of new infections. This escalating situation prompts renewed public health vigilance and a focus on preventative measures.

The outbreak, initially identified as monkeypox, has been officially renamed Mpox by the World Health Organization (WHO) to mitigate stigma and address concerns about racist and discriminatory language associated with the previous name. This change reflects a broader effort to promote inclusivity and accurate public health communication.

Understanding Mpox: Symptoms, Transmission, and Prevention

Mpox is a viral infection that can cause a range of symptoms, typically beginning with fever, headache, muscle aches, and swollen lymph nodes. A characteristic rash then develops, often starting on the face and spreading to other parts of the body. The rash progresses through several stages, eventually forming blisters that scab over.

Transmission occurs through close, personal contact with an infected person or animal, or with materials contaminated with the virus, such as clothing or bedding. This can include direct contact with the rash, scabs, or body fluids. While historically associated with travel to Central and West Africa, the current outbreak demonstrates wider transmission patterns.

Vaccination is a key preventative measure. The JYNNEOS vaccine is approved for the prevention of Mpox and is being deployed in affected areas. Beyond vaccination, practicing good hygiene, avoiding close contact with infected individuals, and safe sexual practices are crucial in limiting the spread of the virus.

Current Situation in Réunion and Mayotte

Réunion has launched a vaccination campaign targeting at-risk populations, aiming to curb the spread of Mpox within the island community. Linfo.re reports that the campaign is focused on providing access to the vaccine for those most vulnerable.

Mayotte is experiencing a more significant surge in cases, with six confirmed infections reported by The Mayotte Journal. The local health authority (ARS) has strengthened its response, including increased surveillance and contact tracing. Overseas the 1st details the identification of three new cases this Thursday, adding to the growing concern.

In mainland France, a single case has been detected, as reported by sante-sur-le-net.com, prompting local health officials to implement standard monitoring protocols.

Another vaccination campaign has been launched in Réunion, as detailed by Imaz Press.

What role do you think international collaboration will play in controlling the spread of Mpox? And how can public health messaging be improved to address vaccine hesitancy and promote preventative behaviors?

Frequently Asked Questions About Mpox

Q: What is the difference between monkeypox and Mpox?

A: Mpox is the newly designated name for the virus formerly known as monkeypox. The change was made to address concerns about stigmatizing language and promote a more inclusive and accurate public health narrative.

Q: How effective is the JYNNEOS vaccine against Mpox?

A: The JYNNEOS vaccine has demonstrated significant effectiveness in preventing Mpox, particularly when administered before exposure. Studies suggest it provides strong protection against severe illness and transmission.

Q: What should I do if I suspect I have Mpox?

A: If you develop symptoms consistent with Mpox, such as fever, headache, and a characteristic rash, it’s crucial to contact your healthcare provider immediately. Avoid close contact with others and follow their guidance.

Q: Is Mpox a sexually transmitted infection (STI)?

A: While Mpox can be transmitted through sexual contact, it is not exclusively an STI. Transmission occurs through close, personal contact, regardless of sexual orientation or activity.

Q: How can I protect myself from contracting Mpox?

A: Vaccination is the most effective preventative measure. Additionally, practicing good hygiene, avoiding close contact with infected individuals, and being mindful of potential exposures can significantly reduce your risk.

Stay informed and vigilant. Public health officials continue to monitor the situation closely and provide updates as they become available.

Share this article to help raise awareness about Mpox and promote preventative measures. Join the conversation in the comments below!

Disclaimer: This article provides general information about Mpox and should not be considered medical advice. Consult with a qualified healthcare professional for diagnosis and treatment.


Discover more from Archyworldys

Subscribe to get the latest posts sent to your email.

You may also like